Cray C et al., 2022-08: A veterinary pathology review of fenbendazole's biologic effects, including use in laboratory rodent deworming and the observation that medicated diets can suppress xenograft growth and confound cancer studies.
A serendipitous finding supported potential antitumorigenic effects of fenbendazole. During a therapeutic fenbendazole regimen in SCID mice, investigators observed that a lymphoma xenograft model failed to grow.
Cray C et al., 2022-08: A veterinary pathology review of fenbendazole's biologic effects, including use in laboratory rodent deworming and the observation that medicated diets can suppress xenograft growth and confound cancer studies. C8/F1. Study type: narrative review; country USA (University of Miami); funder/conflicts not read. The quoted passage is the review's own account of the Gao 2008 observation. Useful because it treats fenbendazole as an animal drug whose antitumour effect in mice confounds research (medicated diets suppressing xenografts), not as a human therapy. Quote verified against the PMC page text. Study type: review.
